![Safety [R]Evolution](https://pbcdn1.podbean.com/imglogo/image-logo/21151572/Safety_R_evolution_Podbean_Tile_2048x20487sh18.png){kind=logo}
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇨🇦CA · Life Sciences#1695K to 30K
- 🇩🇰DK · Life Sciences#2210K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
7.5K to 30K🎙 ~2x weekly·7 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
15K to 60K🇨🇦50%🇩🇰50% - Active Followers
Loyal subscribers who consistently listen
6K to 24K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
The Safety Nucleus: From Compliance to Strategic Enabler
Apr 8, 2026
31m 03s
Humanizing PV: Better Patient Experience, Better Safety Data
Mar 3, 2026
29m 54s
Bringing Safety Operations and Science Together: Big Bang Approach
Feb 2, 2026
33m 06s
Building a Connected Safety Platform for the Future
Dec 10, 2025
28m 38s
Strengthening Safety Oversight for CRO-Sponsor Partnerships
Nov 3, 2025
36m 00s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | |
|---|---|---|---|---|
| 4/8/26 |  The Safety Nucleus: From Compliance to Strategic Enabler | Ipsen’s Pav Rishiraj joins David Kološić to discuss why pharmacovigilance is the nucleus of the industry, and how moving from reactive to predictive safety will improve benefit-risk analysis and establish safety as a strategic enabler for the entire business. | 31m 03s | |
| 3/3/26 |  Humanizing PV: Better Patient Experience, Better Safety Data | In this episode of Safety [R]Evolution, Andrew Rut joins David Kološić to discuss shifting PV from reactive data collection and reporting to a predictive, digital-first model that carefully considers the patient experience, integrates AI and automation, and positions safety as a competitive advantage. | 29m 54s | |
| 2/2/26 |  Bringing Safety Operations and Science Together: Big Bang Approach | UCB’s Adrian Maynier and Veeva’s Mayuran Croos join David Kološić to discuss how to approach a “big bang” consolidation of 17 siloed safety systems into one unified platform for case processing, reporting, signal detection, and content. | 33m 06s | |
| 12/10/25 |  Building a Connected Safety Platform for the Future | David Kološić speaks with Veeva’s Marius Mortensen about the long-term vision for Veeva Safety; the benefits of starting with a trusted, validated cloud platform; and how a platform approach enables connected data and processes, advanced automation, and AI. | 28m 38s | |
| 11/3/25 |  Strengthening Safety Oversight for CRO-Sponsor Partnerships | Biomapas’ Martijn van de Leur and Olga Asimaki join David Kološić to discuss the importance of CRO-sponsor partnerships in pharmacovigilance. They also talk about the need for simplification and standardization, progress on automation and AI, and how QPPV’s are adapting to shifting technology. | 36m 00s | |
| 10/2/25 |  Three Pillars of PV Transformation: Technology, Process, and People | In Episode 2, Eliquent Life Sciences’ Emma-Jane Brookes and Jamie Portnoff speak with David Kološić about simplifying and standardizing PV technology, harmonizing processes across teams and regions, and driving PV transformation through effective change management. Disclaimer: The views expressed are those of the individuals and do not represent Eliquent Life Sciences. | 33m 36s | |
| 8/28/25 |  Building the Right Data and Technology Foundation for Safety | In our launch episode, David Kološić talks with Sandoz’s Aniket Agarwal about how the right data and technology foundation improves speed and operational efficiency for pharmacovigilance teams. We also discuss the benefits and challenges of automation and AI, and where rapidly evolving technologies will take safety in the future. Disclaimer: The views expressed are those of the individual and do not represent Sandoz. | 31m 21s |
Showing 7 of 7
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.